Leire Arrizabalaga

Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications

I. Melero, P. Berraondo, Á. Teijeira, 2021, Cancers.

Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity

F. Corrales, P. Berraondo, S. Ciordia, 2021, Frontiers in Immunology.

Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis

I. Melero, P. Berraondo, H. Hochrein, 2022, Oncoimmunology.

Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models

I. Melero, P. Berraondo, Á. Teijeira, 2022, Oncoimmunology.

Overcoming the limitations of cytokines to improve cancer therapy.

I. Melero, P. Berraondo, Fernando Aranda, 2022, International review of cell and molecular biology.

Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure

I. Melero, P. Berraondo, A. van Elsas, 2023, Molecular therapy. Nucleic acids.

Unveiling the multifaceted antitumor effects of interleukin 33

P. Berraondo, Leire Arrizabalaga, Aline Risson, 2024, Frontiers in Immunology.

Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C

P. Berraondo, H. Lauterbach, Claudia Augusta Di Trani, 2024, Journal for ImmunoTherapy of Cancer.